• Physiological stress response patterns during a blood donation

  M. D. Hoogerwerf, I. J. T. Veldhuizen M. P. Tarvainen E.-M. Merz E. M. J. Huis in ‘t Veld W. L. A - 2018-03-24

• Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use

  Y. Lin, R. Cohen, C. Armali, J. Callum, C. Cserti-Gazdewich, L. Lieberman, J. Pendergrast - 2018-03-08

• Extending shelf life of dithiothreitol-treated panel RBCs to 28 days

  J.-P. Sigle, B. Mihm, R. Suno, M. Bargetzi - 2018-03-07

• Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality

  U. Gravemann, W. Handke, C. Sumian, I. Alvarez, S. Reichenberg, T. H. Müller, A. Seltsam - 2018-02-27

• The B allele with a 5·8 kb deletion in intron 1 of the ABO gene is the major allele in Japanese individuals with Bm and A1Bm phenotypes

  K. Ogasawara, T. Miyazaki, S. Ito, R. Yabe, M. Uchikawa, T. Enomoto, N. Yokoya, Y. Hori, M. Kumamoto - 2018-02-23

• Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions

  L. Waters, M. Cameron, M. P. Padula, D. C. Marks, L. Johnson - 2018-02-14

• Transfusion-transmitted hepatitis B virus (HBV) infection from an individual-donation nucleic acid (ID-NAT) non-reactive donor

  N. O'Flaherty, I. Ushiro-Lumb, L. Pomeroy, S. Ijaz, F. Boland, C. De Gascun, J. Fitzgerald, J. O'Rio - 2018-02-14

• Donor understandings of blood and the body in relation to more frequent donation

  R. Lynch, S. Cohn - 2018-02-09

• Daratumumab: Therapeutic asset, biological trap!

  V. Deneys, C. Thiry, A. Frelik, C. Debry, B. Martin, C. Doyen - 2018-02-05